Can a short class make people safer against infections?
NCT ID NCT07790367
First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time
Summary
This trial tests whether a structured education program can improve how adults perceive infectious diseases, recognize risks, and adopt protective behaviors. Around 200 adults from a family health center will either receive the program or continue with routine care. The program covers transmission routes, hand hygiene, mask use, and immunity. Researchers measure changes in risk awareness, perception, and preventive behaviors after four weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A face-to-face educational program based on Protection Motivation Theory, covering infection transmission, hand hygiene, mask use, and immunity.
- What this could lead to
- If effective, this program could become a low-cost way to help adults adopt habits that reduce the spread of infectious diseases.
- What could go wrong
- The trial is small and short, measuring self-reported changes over four weeks. It may not show lasting behavior change or apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being 18 years of age or older. * Being registered with and receiving services from the family health center where the study is conducted. * Being able to communicate in Turkish. * Voluntarily agreeing to participate in the study. * Being able to complete the study questionnaires and participate in the educational intervention. Exclusion Criteria: * Having a condition that prevents effective communication or participation in the educational intervention. * Declining to participate or withdrawing consent at any stage of the study. * Failing to complete the required pre-intervention or post-intervention assessments.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infectious disease prevention are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Van Yuzuncu Yil University
Van, Van, 65100, Turkey (Türkiye)